Table 2.
Activity of Punicalagin | Model | Experimental Outcome | Ref. |
---|---|---|---|
Antioxidant | l-NAME induced hypertension pregnant rats | Punicalagin supplement decreased the levels of oxidative stress | [42] |
CCl4-induced mice liver injury | Punicalagin decreased MDA level, increased SOD, GPX activities and Nrf2 expression | [43] | |
Anti-viral | Epithelial Vero host cell | Punicalagin reduction the virucidal plaque of HSV-1 | [44] |
Anti-microbial | Aspergillus flavus CECT2686, Aspergillus parasiticus CECT 2947, etc. | Pomegranate peel methanolic extracts inhibited the growth of Aspergillus flavus, Fusarium verticillioides, Alternaria alternata and Botrytis cinerea. | [45] |
Staphylococcus aureus | Punicalagin increased potassium efflux and exerted inhibitory effect on biofilm formation of Staphylococcus aureus. | [47] | |
Anti-cancer | Colorectal cancer cell HCT116 | Punicalagin exhibits selective cytotoxicity on HCT116 compared to CCD841, exerts anti-cancer effect by downregulated Anx-A1 protein. | [49] |
l-NAME: NG-nitro-L-arginine methyl ester; CCl-4: Carbon tetrachloride; HSV: Herpes simplex virus.